SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Exhibiting at 18th ESSKA conference

8 May 2018 07:00

RNS Number : 1647N
Collagen Solutions PLC
08 May 2018
 

 

8 May 2018

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

Collagen Solutions to Exhibit at 18th ESSKA Conference

"European Society of Sports Traumatology, Knee Surgery and Arthroscopy"

Dates: 9-12 May, SEEC, Glasgow

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, confirms that it will be exhibiting at the prestigious ESSKA conference being held in Glasgow between 9-12 May.

 

The ESSKA Congress, held every two years, is a major event in the pan-European calendar that brings together leading medical specialists, including orthopaedic surgeons, clinicians and scientists.

 

Collagen Solutions will be primarily highlighting the recent positive data reported for its most advanced regenerative proprietary product, ChondroMimetic®, an arthroscopic, single-surgery, cost-effective solution for osteochondral defect repair. Earlier this year, the Company announced positive eight year follow-on data for ChondroMimetic® demonstrating durable cartilage regeneration in keyhole knee surgery. These results have allowed Collagen Solutions to begin the submission process to re-establish the CE Mark.

 

 

Commenting on the conference, Jamal Rushdy, CEO said: "We are delighted to be exhibiting at the pre-eminent ESSKA where we will be showcasing ChondroMimetic®. This conference will give us the opportunity to actively engage with specialists and potential partners. Being able to demonstrate the key advantages of ChondroMimetic® over current therapies within this venue is a key part of our strategy of successfully commercialising ChondroMimetic®."

 

 

 

Collagen Solutions PlcJamal Rushdy, Chief Executive OfficerHilary Spence, Chief Financial OfficerLisa Baderoon, Head of Investor Relations

Tel: +44 (0) 141 648 9100Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com

Cenkos Securities plc (NOMAD and Broker)Stephen KeysSteve Cox

Tel: +44 (0) 207 397 8900

Walbrook PRAnna DunphyHelen Cresswell

Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.comMob: +44 (0) 7876 741 001

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

What is ESSKA?

ESSKA represents Europe in the fields of degenerative disease and sports medicine. ESSKA achieves this by:

•Bringing together the practitioners: orthopaedic doctors, the surgeons and their various societies•Fostering research and education, and the exchange of clinical and scientific information•Organising courses, congresses and fellowship programmes•Publishing its journals, books and newsletter to keep its members at the forefront of development

In all this, ESSKA's aim is to improve patients' quality-of-life, by improving the quality of their treatment.

For more information go to: www.esska.org

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUSRKRWOAVRRR
Date   Source Headline
6th Nov 202010:08 amRNSHolding(s) in Company
27th Oct 202010:00 amRNSHolding(s) in Company
27th Oct 202010:00 amRNSHolding(s) in Company
23rd Oct 202011:32 amRNSResult of AGM
20th Oct 20205:30 pmRNSCollagen Solutions
20th Oct 20207:03 amRNSCollagen Solutions Acquired by Rosen’s Diversified
20th Oct 20207:03 amRNSDirector/PDMR Shareholding
20th Oct 20207:03 amRNSAllotment of shares to employee benefit trust
20th Oct 20207:03 amRNSRecommended cash offer for Collagen Solutions
20th Oct 20207:00 amRNSOFFER DECLARED UNCONDITIONAL IN ALL RESPECTS
9th Oct 20209:49 amRNSForm 8.5 (EPT/NON-RI)
6th Oct 20207:00 amRNSExtension of Offer and Acceptance Levels
2nd Oct 20208:30 amRNSForm 8.5 (EPT/NON-RI)
29th Sep 20209:36 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
28th Sep 20209:11 amRNSForm 8.5 (EPT/NON-RI)
25th Sep 20201:02 pmRNSNotice of AGM
24th Sep 20208:32 amRNSForm 8.5 (EPT/NON-RI)
23rd Sep 202010:01 amRNSForm 8.5 (EPT/NON-RI)
18th Sep 20209:07 amRNSForm 8.5 (EPT/NON-RI)
17th Sep 20209:42 amRNSForm 8.3 - Collagen Solutions PLC
17th Sep 20208:29 amRNSForm 8.5 (EPT/NON-RI)
15th Sep 20201:04 pmRNSForm 8.3 - Collagen Solutions
15th Sep 20209:19 amRNSForm 8.5 (EPT/NON-RI)
14th Sep 202011:00 amRNSPosting of Offer Document
14th Sep 20209:13 amRNSForm 8.5 (EPT/NON-RI)
11th Sep 20209:20 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 20203:53 pmRNSForm 8.3 - Collagen Solutions
9th Sep 202010:23 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20209:25 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
7th Sep 20202:19 pmRNSForm 8.3 - Collagen Solutions
7th Sep 20209:40 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
4th Sep 202011:27 amRNSForm 8.3 - Collagen Solutions
3rd Sep 20208:38 amRNSForm 8.5 (EPT/NON-RI)
2nd Sep 20204:30 pmRNSForm 8 (OPD) (Offeror - Rosen's Diversified, Inc.)
2nd Sep 20201:59 pmRNSForm 8.3 - Collagen Solutions
2nd Sep 202011:17 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
2nd Sep 202010:23 amRNSForm 8.3 - [COLLAGEN SOLUTIONS PLC]
2nd Sep 20208:26 amRNSForm 8.5 (EPT/NON-RI)
1st Sep 20202:45 pmRNSForm 8.3 - Collagen Solutions plc
1st Sep 202012:48 pmRNSForm 8.3 - Collagen Solutions plc (Amendment)
1st Sep 202010:25 amRNSForm 8.3 - Collagen Solutions plc
1st Sep 20209:38 amRNSForm 8.3 - Collagen Solutions
1st Sep 20209:36 amRNSForm 8.3 - Collagen Solutions
1st Sep 20209:29 amRNSForm 8 (DD) - Collagen Solutions
1st Sep 20207:58 amRNSForm 8.5 (EPT/NON-RI)
28th Aug 20205:25 pmRNSForm 8 (DD) - Collagen Solutions
28th Aug 20203:27 pmRNSDirector/PDMR Shareholding
28th Aug 20201:34 pmGNWForm 8.3 - Collagen Solutions Plc [Amendment]
28th Aug 202010:24 amGNWForm 8.3 - Collagen Solutions Plc
28th Aug 20208:15 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.